ASTRAZENECA revenue breakdown overview

ASTRAZENECA revenue for the last year amounted to 38.57 B CHF, the most of which — 14.78 B CHF — came from its highest performing source at the moment, Oncology, the year earlier bringing 13.28 B CHF. The greatest contribution to the revenue figure was made by United States — last year it brought ASTRAZENECA 15.62 B CHF, and the year before that — 15.69 B CHF.